Fractyl Health, Inc. Operating Expenses
Fractyl Health, Inc. (GUTS) reported Operating Expenses of $19.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- Fractyl Health, Inc. operating expenses for the quarter ending 2026-06-30 was $19.10M, a 26.78% decline year-over-year.
- Fractyl Health, Inc. operating expenses for the quarter ending 2026-03-31 was $20.82M, a 15.91% decline year-over-year.
- Fractyl Health, Inc. operating expenses for the quarter ending 2025-12-31 was $23.28M, a 7.65% decline year-over-year.
- Fractyl Health, Inc. operating expenses for the quarter ending 2025-09-30 was $22.69M, a 4.65% decline year-over-year.
- Fractyl Health, Inc. operating expenses for fiscal 2025 was $96.82M, a 3.46% increase from fiscal 2024.
- Fractyl Health, Inc. operating expenses for fiscal 2024 was $93.57M, a 83.91% increase from fiscal 2023.
- Fractyl Health, Inc. operating expenses for fiscal 2023 was $50.88M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.10M 10-Q · filed 2026-08-10 | $39.92M 10-Q · filed 2026-08-10 | $63.20M derived: sum of 3 quarters · filed 2026-08-10 | $85.89M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $20.82M 10-Q · filed 2026-05-12 | $44.10M derived: sum of 2 quarters · filed 2026-05-12 | $66.80M derived: sum of 3 quarters · filed 2026-05-12 | $92.88M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $23.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $45.98M derived: sum of 2 quarters · filed 2026-03-24 | $72.06M derived: sum of 3 quarters · filed 2026-08-10 | $96.82M 10-K · filed 2026-03-24 |
| 2025-09-30 | $22.69M 10-Q · filed 2025-11-12 | $48.77M derived: sum of 2 quarters · filed 2026-08-10 | $73.53M 10-Q · filed 2025-11-12 | $98.75M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $26.08M 10-Q · filed 2026-08-10 | $50.84M 10-Q · filed 2026-08-10 | $76.05M derived: sum of 3 quarters · filed 2026-08-10 | $99.85M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $24.76M 10-Q · filed 2026-05-12 | $49.97M derived: sum of 2 quarters · filed 2026-05-12 | $73.77M derived: sum of 3 quarters · filed 2026-05-12 | $96.78M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $25.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $49.01M derived: sum of 2 quarters · filed 2026-03-24 | $72.02M derived: sum of 3 quarters · filed 2026-03-24 | $93.57M 10-K · filed 2026-03-24 |
| 2024-09-30 | $23.80M 10-Q · filed 2025-11-12 | $46.80M derived: sum of 2 quarters · filed 2025-11-12 | $68.36M 10-Q · filed 2025-11-12 | $81.35M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $23.00M 10-Q · filed 2025-08-12 | $44.56M 10-Q · filed 2025-08-12 | $57.55M derived: sum of 3 quarters · filed 2025-08-12 | $71.43M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $21.56M 10-Q · filed 2025-05-13 | $34.54M derived: sum of 2 quarters · filed 2025-05-13 | $48.43M derived: sum of 3 quarters · filed 2025-05-13 | $60.33M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $26.87M derived: sum of 2 quarters · filed 2025-03-03 | $38.77M derived: sum of 3 quarters · filed 2025-03-03 | $50.88M 10-K · filed 2025-03-03 |
| 2023-09-30 | $13.88M 10-Q · filed 2024-11-12 | $25.78M derived: sum of 2 quarters · filed 2024-11-12 | $37.89M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $11.90M 10-Q · filed 2024-08-14 | $24.01M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $12.11M 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |